Search
Search Results
##search.searchResults.foundPlural##
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3909PDF: 1007HTML: 6898 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1370PDF: 597HTML: 23267 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2735PDF: 937HTML: 9086Efremov 1: 288Efremov 2: 260 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1252PDF: 1334HTML: 150 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7619PDF: 4189HTML: 25008 -
Acquired Hemophilia A successfully treated with rituximab
2376PDF: 1236HTML: 1536Figure 1: 251 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2177PDF: 2056HTML: 813 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3931PDF: 1387HTML: 3981Untitled: 301Untitled: 326 -
How I treat acute and persistent sickle cell pain
2189PDF: 1215HTML: 809 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3628PDF: 1369HTML: 8440 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1928PDF: 639HTML: 17008Figure 4: 239Figure 3: 203Figure 2: 201Figure 1: 231 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1303PDF: 898HTML: 3430 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1785PDF: 910HTML: 1295Figure 1: 228Figure 2: 238Figure 3: 243 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2413PDF: 1721HTML: 765 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
953PDF: 536HTML: 1333 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1665PDF: 1046HTML: 277 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2893PDF: 1035HTML: 618 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1551PDF: 994HTML: 437 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
3052PDF: 1054HTML: 674 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6473PDF: 3534HTML: 9080Figure Malaria Ricci: 299 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1342PDF: 597HTML: 1729Figures: 223Fifures Sanz: 234tables Sanz: 236Untitled: 229 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4518PDF: 2066HTML: 5577Table 1: 316 -
-
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
2050PDF: 1086HTML: 411 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3115PDF: 1484HTML: 3749Untitled: 280Untitled: 277Untitled: 225







